The UK government has granted environmental approval for Shell's Jackdaw gasfield in the North Sea, allowing it to start supplying gas to UK homes and businesses by the end of October. This decision caused shares of North Sea-focused companies Ithaca Energy and Jersey Oil and Gas to rise significantly. The approval supports UK energy security by increasing domestic gas supply during winter and reducing reliance on imports. While the government remains committed to ending new North Sea oil and gas licenses and achieving net zero emissions by 2050, this move signals regulatory support for existing licensed projects. Attention now shifts to the pending environmental decision on Equinor’s Rosebank oilfield.
The UK government's approval of the Jackdaw gasfield project is notable news for energy markets. For readers following the energy sector, here is Pluang's market snapshot as of Oct 21, 2026 12:41 WIB: Among 79 priced US energy stocks, 44 rose and 33 fell. Notable prices and changes include Noble Corporation plc (NE) at USD 43.18 with a 1-day change of -1.95% and 100% sell order activity, TC Energy Corporation (TRP) at USD 61.76 up 1.76%, and Schlumberger NV (SLB) at USD 49.95 up 1.75% with 95% sell order activity and a typical hold time of 100 days.
A webinar titled "Ready for AI?" scheduled for October 29, 2026, will discuss how artificial intelligence is reshaping public relations by changing how information is found, evaluated, and shared. Experts will share insights on maintaining message vi...
17a-4 LLC introduced DataParser Hub, an API that enables clients to integrate proprietary messaging and collaboration data into Microsoft 365 Purview and Copilot. This solution supports over 30 data types from platforms like Slack, Zoom, and Webex, a...
IBA has treated the first patient in the C-FLASH-01 clinical trial, the first human study testing ConformalFLASH® proton therapy. This trial, conducted at Penn Medicine with FDA approval, explores the feasibility of using ultra-high dose rate proton ...
IBA has treated the first patient in the C-FLASH-01 clinical trial, testing its ConformalFLASH® proton therapy for head and neck cancer re-irradiation. This trial, led by Penn Medicine and approved by the FDA, explores ultra-high dose rate proton the...
WISeQey Corp. completed its redomiciliation and began trading on Nasdaq and the SIX Swiss Exchange, marking a new phase focused on integrating its quantum cybersecurity, digital identity, and space IoT technologies. Its subsidiary WISeSat.Space also ...
